Search

Maxime C Soumeillant

from Princeton, NJ
Age ~59
Get Report
Also known as:
Maxime T
Phone and address:
5 Coppervail Ct, Princeton, NJ 08540
Related to:
Max C SoumeillantAnne Renee, 55
Connected to:
Seth S Soumphonphakdy, 53David Soun, 35Emily S Soun, 35Hye C Soun, 60Jun K Soun, 79Saxon Sounakhen, 36Tim Sounakhen, 41Nancy R Sounart, 57Chelliah Soundar, 66Cheryl O Soundara, 40

Maxime Soumeillant Phones & Addresses

  • 5 Coppervail Ct, Princeton, NJ 08540
  • 49 Mercer St, Trenton, NJ 08690 (609) 689-0554
  • Hamilton, NJ
  • Plainsboro, NJ
  • Minneapolis, MN
  • New Brunswick, NJ
  • 49 Mercer St, Hamilton, NJ 08690

Work

Company: Bristol-myers squibb Jul 2015 Position: Principal scientist

Education

Specialities: Organic Chemistry

Skills

Pharmaceutical Industry • Drug Development • Organic Chemistry • Technology Transfer • Hplc • Organic Synthesis • Gmp • Drug Discovery • Chromatography • Validation • Medicinal Chemistry

Industries

Pharmaceuticals

Resumes

Resumes

Maxime Soumeillant Photo 1

Principal Scientist

View page
Location:
345 Park Ave, New York, NY 10010
Industry:
Pharmaceuticals
Work:
Bristol-Myers Squibb
Principal Scientist
Skills:
Pharmaceutical Industry
Drug Development
Organic Chemistry
Technology Transfer
Hplc
Organic Synthesis
Gmp
Drug Discovery
Chromatography
Validation
Medicinal Chemistry

Publications

Us Patents

Methods For The Preparation Of Hiv Attachment Inhibitor Piperazine Prodrug Compound

View page
US Patent:
20130203992, Aug 8, 2013
Filed:
Feb 6, 2013
Appl. No.:
13/760526
Inventors:
Bristol-Myers Squibb Company - Princeton NJ, US
Michael S. Bultman - Union City NJ, US
Ke Chen - East Brunswick NJ, US
Dayne Dustan Fanfair - East Windsor NJ, US
Richard J. Fox - Yardley PA, US
Thomas E. La Cruz - North Brunswick NJ, US
Boguslaw M. Mudryk - East Windsor NJ, US
Christina Ann Risatti - Princeton NJ, US
James H. Simpson - Hillsborough NJ, US
Maxime C. Soumeillant - Hamilton Square NJ, US
Jonathan Clive Tripp - Westfield NJ, US
Yi Xiao - Fanwood NJ, US
Assignee:
Bristol-Myers Squibb Company - Princeton NJ
International Classification:
C07F 9/6561
C07C 213/08
C07D 471/04
US Classification:
544337, 546113, 544362
Abstract:
A method for making the compoundis set forth utilizing the starting material

Process For The Preparation Of N-((1R,2S,5R)-5-(Tert-Butylamino)-2-((S)-3-(7-Tert-Butylpyrazolo[1,5-A][1,3,5]Triazin-4-Ylamino)-2-Oxopyrrolidin-1-Yl)Cyclohexyl)Acetamide

View page
US Patent:
20220177482, Jun 9, 2022
Filed:
Feb 22, 2022
Appl. No.:
17/677312
Inventors:
- Princeton NJ, US
Collin Chan - New York NY, US
Joerg Deerberg - Columbus NJ, US
Nathan R. Domagalski - Niantic CT, US
Martin D. Eastgate - Titusville NJ, US
Yu Fan - Highland Park NJ, US
Michael David Bengt Fenster - New York NY, US
Robert V. Forest - Hillsborough NJ, US
Rebecca A. Green - Metuchen NJ, US
Matthew R. Hickey - Yardley PA, US
Nathaniel David Kopp - Newtown PA, US
Thomas E. La Cruz - Flemington NJ, US
Kathleen Lauser - Minneapolis MN, US
Hong Geun Lee - Seoul, KR
David K. Leahy - Hightstown NJ, US
Helen Y. Luo - San Francisco CA, US
Thomas M. Razler - Yardley PA, US
Scott A. Savage - Yardley PA, US
Chris Sfouggatakis - Staten Island NY, US
Maxime C.D. Soumeillant - Princeton NJ, US
Serge Zaretsky - Fords NJ, US
Bin Zheng - Kendall Park NJ, US
Ye Zhu - Singapore, SG
International Classification:
C07D 487/04
Abstract:
The invention generally relates to an improved process for the preparation of N-((1R,2S,5R)-5-(tert-butylamino)-2-((S)-3-(7-tert-butylpyrazolo[1,5-a][1,3,5]triazin-4-ylamino)-2-oxopyrrolidin-1-yl)cyclohexyl)acetamide,

Process For The Preparation Of 6-(Cyclopropaneamido)-4-((2-Methoxy-3-(1-Methyl-1H-1,2,4-Triazol-3-Yl)Phenyl)Amino)-N-(Methyl-D3)Pyridazine-3-Carboxamide

View page
US Patent:
20210107897, Apr 15, 2021
Filed:
Dec 22, 2020
Appl. No.:
17/131718
Inventors:
- Princeton NJ, US
Joerg Deerberg - Columbus NJ, US
Dong Lin - Monmouth Junction NJ, US
Michael Dummeldinger - Plainsboro NJ, US
Bahar Inankur - New Brunswick NJ, US
Sergei Kolotuchin - Roselle Park NJ, US
Jun Li - Langhorne PA, US
Amanda J. Rogers - Asbury NJ, US
Victor W. Rosso - Monroe Township NJ, US
Eric M. Simmons - East Brunswick NJ, US
Maxime C.D. Soumeillant - Princeton NJ, US
Daniel S. Treitler - Cranford NJ, US
Jianji Wang - Dayton NJ, US
Bin Zheng - Kendall Park NJ, US
Michael J. Smith - Somerset NJ, US
Neil A. Strotman - Flemington NJ, US
Steven Tymonko - Lindenhurst IL, US
Tamas Benkovics - East Brunswick NJ, US
International Classification:
C07D 403/12
C07C 211/09
C07D 237/24
C07D 249/08
Abstract:
The invention relates to an improved process for synthesizing 6-(cyclopropaneamido)-4-((2-methoxy-3-(1-methyl-1H-1,2,4-triazol-3-yl)phenyl)amino)-N-(methyl-d3)pyridazine-3-carboxamide of the formula:Compound I is currently in clinical trials for the treatment of auto-immune and auto-inflammatory diseases such as psoriasis.

Process For The Preparation Of N-((1R,2S,5R)-5-(Tert-Butylamino)-2-((S)-3-(7-Tert-Butylpyrazolo[1,5-A][1,3,5]Triazin-4-Ylamino)-2-Oxopyrrolidin-1-Yl)Cyclohexyl)Acetamide

View page
US Patent:
20200223852, Jul 16, 2020
Filed:
Jul 19, 2018
Appl. No.:
16/631915
Inventors:
- Princeton NJ, US
Collin Chan - New York NY, US
Joerg Deerberg - Columbus NJ, US
Nathan R. Domagalski - Niantic CT, US
Martin D. Eastgate - Titusville NJ, US
Yu Fan - Highland Park NJ, US
Michael David Bengt Fenster - New York NY, US
Robert V. Forest - Hillsborough NJ, US
Rebecca A. Green - Metuchen NJ, US
Matthew R. Hickey - Yardley PA, US
Nathaniel David Kopp - Newtown PA, US
Thomas E. La Cruz - Flemington NJ, US
Kathleen Lauser - Minneapolis MN, US
Hong Geun Lee - Seoul, KR
David K. Leahy - Hightstown NJ, US
Helen Y. Luo - San Francisco CA, US
Thomas M. Razler - Yardley PA, US
Scott A. Savage - Yardley PA, US
Chris Sfouggatakis - Staten Island NY, US
Maxime C.D. Soumeillant - Princeton NJ, US
Serge Zaretsky - Fords NJ, US
Bin Zheng - Kendall Park NJ, US
Ye Zhu - Singapore, SG
International Classification:
C07D 487/04
Abstract:
The invention generally relates to an improved process for the preparation of N-((1R,2S,5R)-5-(tert-butylamino)-2-((S)-3-(7-tert-butylpyrazolo[1,5-a][1,3,5]triazin-4-ylamino)-2-oxopyrrolodin-1-yl)cyclohexyl)acetamide, as well as novel intermediates employed in the process, which may be useful for the treatment of cancer.

Process For The Preparation Of 6-(Cyclopropaneamido)-4-((2-Methoxy-3-(1-Methyl-1H-1,2,4-Triazol-3-Yl)Phenyl)Amino)-N-(Methyl-D3)Pyridazine-3-Carboxamide

View page
US Patent:
20200109134, Apr 9, 2020
Filed:
Mar 29, 2018
Appl. No.:
16/498442
Inventors:
- Princeton NJ, US
Joerg Deerberg - Columbus NJ, US
Dong Lin - Monmouth Junction NJ, US
Michael Dummeldinger - Plainsboro NJ, US
Bahar Inankur - New Brunswick NJ, US
Sergei Kolotuchin - Roselle Park NJ, US
Jun Li - Langhorne PA, US
Amanda J. Rogers - Asbury NJ, US
Victor W. Rosso - Monroe Township NJ, US
Eric M. Simmons - East Brunswick NJ, US
Maxime C.D. Soumeillant - Princeton NJ, US
Daniel S. Treitler - Cranford NJ, US
Jianji Wang - Dayton NJ, US
Bin Zheng - Kendall Park NJ, US
Michael J. Smith - Somerset NJ, US
Neil A. Strotman - Flemington NJ, US
Steven Tymonko - Lindenhurst IL, US
Tamas Benkovics - East Brunswick NJ, US
International Classification:
C07D 403/12
C07D 249/08
C07C 211/09
C07D 237/24
Abstract:
The invention relates to an improved process for synthesizing 6-(cyclopropaneamido)-4-((2-methoxy-3-(1-methyl-1H-1,2,4-triazol-3-yl)phenyl)amino)-N-(methyl-d3)pyridazine-3-carboxamide of the formula: [INSERT CHEMICAL STRUCTURE HERE] Compound I is currently in clinical trials for the treatment of auto-immune and auto-inflammatory diseases such as psoriasis.

Methods Of Producing An Hiv Maturation Inhibitor

View page
US Patent:
20180072691, Mar 15, 2018
Filed:
Apr 14, 2016
Appl. No.:
15/563635
Inventors:
- Brentford, Middlesex, GB
Maxime SOUMEILLANT - New Brunswick NJ, US
Scott A. SAVAGE - New Brunswick NJ, US
Neil A. STROTMAN - New Brunswick NJ, US
Martin D. EASTGATE - New Brunswick NJ, US
Matthew W. HALEY - New Brunswick NJ, US
Jeanne HO - New Brunswick NJ, US
Jeffrey A. NYE - New Brunswick NJ, US
Zhongmin XU - New Brunswick NJ, US
Susanne KIAU - New Brunswick NJ, US
Tamas BENKOVICS - East Brunswick NJ, US
Yichen TAN - New Brunswick NJ, US
International Classification:
C07D 295/155
C07J 63/00
Abstract:
A method for producing HIV maturation inhibitor compound is set forth using betulinas starting material, and utilizing Lossen rearrangement techniques.

Methods For The Preparation Of Hiv Attachment Inhibitor Piperazine Prodrug Compound

View page
US Patent:
20160152644, Jun 2, 2016
Filed:
Jan 4, 2016
Appl. No.:
14/986816
Inventors:
- Princeton NJ, US
Michael S. Bultman - Allendale NJ, US
Ke Chen - East Brunswickl NJ, US
Dayne Dustan Fanfair - East Windsor NJ, US
Richard J. Fox - Yardley PA, US
Thomas E. La Cruz - North Brunswick NJ, US
Boguslaw M. Mudryk - East Windsor NJ, US
Christina Ann Risatti - Princeton NJ, US
James H. Simpson - Hillsborough NJ, US
Maxime C. Soumeillant - Hamilton Square NJ, US
Jonathan Clive Tripp - Foster City CA, US
Yi Xiao - Fanwood NJ, US
International Classification:
C07F 9/6561
C07C 213/08
Abstract:
A method for making the compoundis set forth utilizing the starting material

Methods For The Preparation Of Hiv Attachment Inhibitor Piperazine Prodrug Compound

View page
US Patent:
20160108029, Apr 21, 2016
Filed:
Oct 17, 2014
Appl. No.:
14/516649
Inventors:
- Princeton NJ, US
Michael S. Bultman - Allendale NJ, US
Ke Chen - East Brunswick NJ, US
Dayne Dustan Fanfair - East Windsor NJ, US
Richard J. Fox - Yardley PA, US
Thomas E. La Cruz - North Brunswick NJ, US
Boguslaw M. Mudryk - East Windsor NJ, US
Christina Ann Risatti - Princeton NJ, US
James H. Simpson - Hillsborough NJ, US
Maxime C. Soumeillant - Hamilton Square NJ, US
Jonathan Clive Tripp - Foster City CA, US
Yi Xiao - Fanwood NJ, US
International Classification:
C07D 471/04
Abstract:
A method for making the compoundis set forth utilizing the starting material
Control profile
Maxime C Soumeillant from Princeton, NJ, age ~59 Get Report